» Articles » PMID: 19375581

Different Pathophysiology of Impaired Glucose Tolerance in First-degree Relatives of Individuals with Type 2 Diabetes Mellitus

Overview
Journal Metabolism
Specialty Endocrinology
Date 2009 Apr 21
PMID 19375581
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

To assess whether an increased genetic predisposition for type 2 diabetes mellitus (T2DM) influences the contributions of insulin resistance and impaired insulin secretion to impaired glucose tolerance (IGT), 437 subjects not known to have T2DM underwent an oral glucose tolerance test and a 3-hour hyperglycemic clamp. Plasma insulin responses and insulin sensitivity were compared between all subjects (unselected for demographic or anthropometric characteristics) who had normal glucose homeostasis and no first-degree T2DM relative (n = 133), IGT with a first-degree T2DM relative (IGT/FH+, n = 74), or IGT without a first-degree T2DM relative (IGT/FH-, n = 50). Compared with those with normal glucose homeostasis, first- and second-phase plasma insulin responses were reduced approximately 45% and 30%, respectively (both P < .001), in IGT/FH+, whereas insulin sensitivity was only approximately 20% reduced (P = .011). In contrast, in IGT/FH-, first-phase plasma insulin responses were only approximately 20% reduced (P = .016), second-phase plasma insulin responses were not reduced, but insulin sensitivity was approximately 40% reduced (P < .001). The IGT/FH+ group differed significantly from the IGT/FH- group by having 25% to 30% lower first-phase plasma insulin responses (P = .026) and 25% to 30% greater insulin sensitivity (P = .027). Adjustment for obesity abolished the differences in insulin resistance but not plasma insulin responses. However, when the IGT groups were stratified into subgroups based on body mass index (BMI), first-phase plasma insulin responses were approximately 30% lower in IGT/FH+ with a BMI of at least 27 kg/m(2) (P = .018) but similar in IGT/FH+ with a BMI less than 27 kg/m(2) compared with the corresponding IGT/FH- subgroups. We conclude that, in IGT, an increased genetic predisposition for T2DM increases the contribution of impaired insulin secretion to its pathophysiology. This effect is enhanced by obesity.

Citing Articles

Hypoglycemia and anxiolysis mediated by levofloxacin treatment in diabetic rats.

Singh P, Walia V, Verma P J Diabetes Metab Disord. 2023; 22(2):1197-1209.

PMID: 37975146 PMC: 10638278. DOI: 10.1007/s40200-023-01234-0.


Comparison of area under the curve in various models of diabetic rats receiving chronic medication.

Liu K, Niu C, Tsai J, Yang C, Peng W, Niu H Arch Med Sci. 2022; 18(4):1078-1087.

PMID: 35832712 PMC: 9266878. DOI: 10.5114/aoms.2019.91471.


Impact of A Cargo-Less Liposomal Formulation on Dietary Obesity-Related Metabolic Disorders in Mice.

Komalla V, Sheikholeslami B, Li G, Bokshi B, Chan Y, Ung A Int J Mol Sci. 2020; 21(20).

PMID: 33076522 PMC: 7589567. DOI: 10.3390/ijms21207640.


Glucose-dependent phosphorylation signaling pathways and crosstalk to mitochondrial respiration in insulin secreting cells.

Santo-Domingo J, Nunez Galindo A, Cominetti O, De Marchi U, Cutillas P, Dayon L Cell Commun Signal. 2019; 17(1):14.

PMID: 30786936 PMC: 6381748. DOI: 10.1186/s12964-019-0326-6.


Family history of diabetes, lifestyle factors, and the 7-year incident risk of type 2 diabetes mellitus in middle-aged Japanese men and women.

Sakurai M, Nakamura K, Miura K, Takamura T, Yoshita K, Sasaki S J Diabetes Investig. 2014; 4(3):261-8.

PMID: 24843664 PMC: 4015662. DOI: 10.1111/jdi.12033.


References
1.
Abumrad N, Rabin D, Diamond M, LACY W . Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism. 1981; 30(9):936-40. DOI: 10.1016/0026-0495(81)90074-3. View

2.
Abdul-Ghani M, Tripathy D, DeFronzo R . Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006; 29(5):1130-9. DOI: 10.2337/diacare.2951130. View

3.
Harris M . Impaired glucose tolerance--prevalence and conversion to NIDDM. Diabet Med. 1996; 13(3 Suppl 2):S9-11. View

4.
. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006; 30 Suppl 1:S42-7. DOI: 10.2337/dc07-S042. View

5.
Larsson H, Ahren B . Islet dysfunction in obese women with impaired glucose tolerance. Metabolism. 1996; 45(4):502-9. DOI: 10.1016/s0026-0495(96)90227-9. View